OBJECTIVES: To determine whether atrial fibrillation (AF) is associated with risk of incident dementia or Alzheimer's disease (AD), beyond its effect on stroke. DESIGN: Prospective cohort study. SETTING: An integrated healthcare delivery system. PARTICIPANTS: A population-based sample of 3,045 community-dwelling adults aged 65 and older without dementia or clinical stroke followed from 1994 to 2008. MEASUREMENTS: AF was identified from health plan electronic data using International Classification of Diseases, Ninth Revision, codes from inpatient and outpatient encounters. Covariates came from self-report, study measures, and health plan data. Participants were screened every 2 years using the Cognitive Abilities Screening Instrument (range 0-100), with detailed neuropsychological and clinical assessment of those scoring less than 86. A multidisciplinary consensus committee determined diagnoses of all-cause dementia and possible or probable AD using standard research criteria. RESULTS: AF was present in 132 (4.3%) participants at baseline and was diagnosed in 370 (12.2%) more over a mean of 6.8 years of follow-up; 572 participants (18.8%) developed dementia (449 with AD). The adjusted hazard ratio associated with AF was 1.38 (95% confidence interval (CI)=1.10-1.73) for all-cause dementia and 1.50 (95% CI=1.16-1.94) for possible or probable AD. Results were similar for participants with and without clinically recognized stroke during follow-up and in sensitivity analyses examining only probable AD. CONCLUSION: AF is associated with higher risk of developing AD and dementia. Future studies should examine whether specific treatments, including optimal anticoagulation, can decrease this risk.
OBJECTIVES: To determine whether atrial fibrillation (AF) is associated with risk of incident dementia or Alzheimer's disease (AD), beyond its effect on stroke. DESIGN: Prospective cohort study. SETTING: An integrated healthcare delivery system. PARTICIPANTS: A population-based sample of 3,045 community-dwelling adults aged 65 and older without dementia or clinical stroke followed from 1994 to 2008. MEASUREMENTS: AF was identified from health plan electronic data using International Classification of Diseases, Ninth Revision, codes from inpatient and outpatient encounters. Covariates came from self-report, study measures, and health plan data. Participants were screened every 2 years using the Cognitive Abilities Screening Instrument (range 0-100), with detailed neuropsychological and clinical assessment of those scoring less than 86. A multidisciplinary consensus committee determined diagnoses of all-cause dementia and possible or probable AD using standard research criteria. RESULTS:AF was present in 132 (4.3%) participants at baseline and was diagnosed in 370 (12.2%) more over a mean of 6.8 years of follow-up; 572 participants (18.8%) developed dementia (449 with AD). The adjusted hazard ratio associated with AF was 1.38 (95% confidence interval (CI)=1.10-1.73) for all-cause dementia and 1.50 (95% CI=1.16-1.94) for possible or probable AD. Results were similar for participants with and without clinically recognized stroke during follow-up and in sensitivity analyses examining only probable AD. CONCLUSION:AF is associated with higher risk of developing AD and dementia. Future studies should examine whether specific treatments, including optimal anticoagulation, can decrease this risk.
Authors: J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: Walter A Kukull; Roger Higdon; James D Bowen; Wayne C McCormick; Linda Teri; Gerard D Schellenberg; Gerald van Belle; Lance Jolley; Eric B Larson Journal: Arch Neurol Date: 2002-11
Authors: Olivier Piguet; David A Grayson; Helen Creasey; Hayley P Bennett; William S Brooks; Louise M Waite; G Anthony Broe Journal: Neuroepidemiology Date: 2003 May-Jun Impact factor: 3.282
Authors: Teresa S M Tsang; George W Petty; Marion E Barnes; W Michael O'Fallon; Kent R Bailey; David O Wiebers; JoRean D Sicks; Teresa J H Christianson; James B Seward; Bernard J Gersh Journal: J Am Coll Cardiol Date: 2003-07-02 Impact factor: 24.094
Authors: Reijo S Tilvis; Mervi H Kähönen-Väre; Juha Jolkkonen; Jaakko Valvanne; Kaisu H Pitkala; Timo E Strandberg Journal: J Gerontol A Biol Sci Med Sci Date: 2004-03 Impact factor: 6.053
Authors: Wai Kwong Tang; Sandra S M Chan; Helen F K Chiu; Gabor S Ungvari; Ka Sing Wong; Timothy C Y Kwok; Vincent Mok; K T Wong; Polly S Richards; A T Ahuja Journal: J Neurol Date: 2004-05 Impact factor: 4.849
Authors: Shadi Kalantarian; Hakan Ay; Randy L Gollub; Hang Lee; Kallirroi Retzepi; Moussa Mansour; Jeremy N Ruskin Journal: Ann Intern Med Date: 2014-11-04 Impact factor: 25.391
Authors: Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin Journal: Circulation Date: 2012-06-12 Impact factor: 29.690
Authors: M Gosch; R E Roller; B Böhmdorfer; U Benvenuti-Falger; B Iglseder; M Lechleitner; U Sommeregger; P Dovjak Journal: Z Gerontol Geriatr Date: 2012-01 Impact factor: 1.281
Authors: Michael L Alosco; Mary Beth Spitznagel; Lawrence H Sweet; Richard Josephson; Joel Hughes; John Gunstad Journal: Pacing Clin Electrophysiol Date: 2014-12-10 Impact factor: 1.976